Muscle Atrophy in Chronic Kidney Disease

Area of Science:

• Nephrology
• Muscle Physiology
• Pathophysiology

Background:

• Chronic kidney disease (CKD) leads to systemic alterations impacting muscle homeostasis.
• CKD-induced muscle atrophy is prevalent, contributing to reduced physical capacity, functional independence, and increased mortality.
• The complex interactions between CKD factors and muscle atrophy mechanisms require further investigation.

Purpose of the Study:

• To summarize current knowledge on the interactions between CKD and muscle atrophy.
• To review the pathophysiological mechanisms underlying CKD-induced muscle atrophy.
• To outline current treatment strategies and identify areas for future research.

Main Methods:

• Literature review of current research on CKD and muscle atrophy.
• Synthesis of information on pathophysiological mechanisms.
• Compilation of existing treatment modalities.

Main Results:

• CKD significantly disrupts muscle homeostasis, leading to atrophy.
• Muscle atrophy in CKD is linked to comorbidities, reduced physical capacity, and higher mortality.
• Current treatments are diverse but require further study for optimization.

Conclusions:

• Understanding CKD-induced muscle atrophy is crucial for improving patient outcomes.
• Multidisciplinary treatments show promise but need further research.
• Continued investigation is essential to refine therapeutic strategies for CKD-related muscle wasting.